Epidemiological survey of acute low-tone sensorineural hearing loss

Sato, Hiroaki; Kuwashima, Shigeru; Nishio, Shin‐ya; Kitoh, Ryosuke; Fukuda, Satoshi; Hara, Akira; Hato, Naohito; Ikezono, Tetsuo; Ishikawa, Kotaro; Iwasaki, Satoshi; Kaga, Kimitaka; Matsubara, Atsushi; Matsunaga, Tatsuo; Murata, Takaaki; Naito, Yasushi; Nakagawa, Takashi; Nishizaki, Kazunori; Noguchi, Yoshihiro; Ogawa, Kaoru; Sano, Hajime; Shojaku, Hideo; Takahashi, Haruo; Tono, Testuya; Yamashita, Hiroshi; Yamasoba, Tatsuya; Usami, Shin Ichi

doi:10.1080/00016489.2017.1297538

Cited by 25 publications

(31 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…With incidence as high as 65.8 per 100000 population, ALHL is recently receiving more attention regarding its epidemiology, treatment, and prognosis. 7) In this study, the demographic data showed marked female preponderance and peak incidence during fourth decade of life, which is comparable to demographic data in previous literature. 8) Of 249 patients who visited our clinic complaining of low-tone hearing loss and ear fullness without vertigo, approximately 20% met criteria for ALHL.…”

Section: Discussionsupporting

confidence: 90%

Update on Clinical Manifestation in Acute Low-Tone Hearing Loss

Kim¹,

Lee²,

Kim³

et al. 2020

Korean J Otorhinolaryngol-Head Neck Surg

View full text Add to dashboard Cite

Background and Objectives Acute low-tone hearing loss (ALHL) is gaining attention as an independent disease identity with close association with endolymphatic hydrops and early stage Meniere’s disease (MD). This study aims to compare patients of ALHL with patients exhibiting low-tone hearing loss and ear fullness without vertigo in various audio-vestibular assessments and in progression to overt MD.Subjects and Method A total of 249 patients with low-tone hearing loss with ear fullness without vertigo was enrolled in this study. Of these patients, 58 patients met criteria for ALHL, which was defined as having an average hearing loss of ≥30 dB at 125, 250, and 500 Hz and ≤20 dB at 2, 4, and 8 kHz. Demographics, electrocochleography (ECoG) abnormality, rate of hearing improvement, vestibular functions, and progression to MD were analyzed.Results An average low-tone hearing loss of ALHL patients was 42.8 dB, which recovered to 18.9 dB following a combined treatment of diuretics and oral steroid therapy. The hearing recovery rate of this group was 87.9% and the ECoG abnormality ratio was 42.5%. Also, 15.5% of ALHL patients eventually progressed to MD.Conclusion This study described demographics and characteristics of ALHL, demonstrating a successful response to the combined treatment of diuretics and oral steroid. Also, this report demonstrated a close relationship between the degree of low-tone hearing loss and ECoG abnormality and observed the progression to MD in ALHL patients. These data can be usefully applied in clinical setting to explain clinical outcomes of ALHL.

show abstract

Section: Discussionsupporting

confidence: 90%

Update on Clinical Manifestation in Acute Low-Tone Hearing Loss

Kim¹,

Lee²,

Kim³

et al. 2020

Korean J Otorhinolaryngol-Head Neck Surg

View full text Add to dashboard Cite

show abstract

“…Low-tone SSNHL differed from the sudden SSNHL in terms of male-to-female ratio, age distribution, pathology (ELH), treatment methods, and high hearing recovery prognosis. They thought that the two diseases belonged to different categories of inner ear disease [Shimono et al, 2013;Im et al, 2016;Sato et al, 2017;Yoshida et al, 2017;Myung et al, 2018;Psillas et al, 2019;Yakunina et al, 2019]. From our study, we speculate that history of migraine maybe another cause of low-tone SSNHL.…”

Section: Discussionmentioning

confidence: 47%

Audiological Findings in Patients with Vestibular Migraine and Migraine: History of Migraine May Be a Cause of Low-Tone Sudden Sensorineural Hearing Loss

Xue

Lin

et al. 2020

Audiol Neurotol

View full text Add to dashboard Cite

Introduction: The aim of this study was to investigate and compare the auditory findings in migraine, vestibular migraine (VM), and healthy controls. Methods: Twenty-eight migraine patients (56 ears), 18 VM (36 ears), and 25 healthy controls (50 ears) were included. Audiometry, speech discrimination scores, distortion product optoacoustic emission (DPOAE), and auditory brainstem response were tested. Results: The pure tone in the VM group showed higher thresholds at lower frequencies (250, 500, 1,000, 2,000 Hz) than the control group, with statistical differences observed (P_{250 Hz} = 0.001, P_{500 Hz} = 0.003, P_{1,000 Hz} = 0.016, P_{2,000 Hz} = 0.002). Compared with the healthy controls, the patients with VM had significantly lower amplitudes of DPOAE at 1 kHz (p < 0.001) and 2 kHz (p = 0.020), and the patients with migraine had lower amplitudes at 2 kHz (p = 0.042). Compared with the control group, the patients with migraine reported prolonged latency of wave V (p = 0.016) and IPL I–V (p = 0.003). The patients with VM had significant prolongation of IPL I–V (p = 0.024). Conclusion: Not only the peripheral, but also the central auditory system was involved in patients with migraine and VM. In particular, lower frequencies of the auditory system were more likely to be involved in VM. The history of migraine may be a cause of low-tone sudden sensorineural hearing loss.

show abstract

“…Most patients were simultaneously treated with vitamin B12 and adenosine triphosphate. The detailed treatments outcome of SSNHL and ALHL are described in other papers in this supplement [8][9][10].…”

Section: Gradementioning

confidence: 99%